SeaStar Medical Holding Corp
ICU2.260USD
-0.150-6.22%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
77.06MMarket Cap
LossP/E TTM
More Details of SeaStar Medical Holding Corp Company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
SeaStar Medical Holding Corp Info
Ticker SymbolICU
Company nameSeaStar Medical Holding Corp
IPO dateJan 26, 2021
CEOSchlorff (Eric)
Number of employees19
Security typeOrdinary Share
Fiscal year-endJan 26
Address3513 Brighton Blvd
CityDENVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80216
Phone18444278100
Websitehttps://seastarmedical.com
Ticker SymbolICU
IPO dateJan 26, 2021
CEOSchlorff (Eric)
Company Executives of SeaStar Medical Holding Corp
Name
Name/Position
Position
Shareholding
Change
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
8.27K
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
5.52K
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
3.32K
--
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
2.69K
+420.00%
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
267.00
--
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Mr. Michael Hollan Messinger, CPA
Mr. Michael Hollan Messinger, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
8.27K
--
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
5.52K
--
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
3.32K
--
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
2.69K
+420.00%
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
267.00
--
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Dec 13
Updated: Sat, Dec 13
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.72%
Millennium Management LLC
0.50%
Neuman (John)
0.23%
Schlorff (Eric)
0.15%
Other
97.35%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.72%
Millennium Management LLC
0.50%
Neuman (John)
0.23%
Schlorff (Eric)
0.15%
Other
97.35%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.49%
Individual Investor
0.79%
Investment Advisor/Hedge Fund
0.75%
Hedge Fund
0.50%
Research Firm
0.14%
Venture Capital
0.13%
Bank and Trust
0.01%
Other
96.18%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
55
109.39K
3.03%
-5.17K
2025Q3
56
847.20K
2.48%
-188.93K
2025Q2
64
1.04M
4.18%
+532.11K
2025Q1
64
1.12M
9.53%
+609.78K
2024Q4
56
403.35K
5.53%
-59.49K
2024Q3
101
532.19K
15.84%
-408.40K
2024Q2
105
549.58K
17.81%
-317.45K
2024Q1
106
490.37K
46.99%
-245.21K
2023Q4
100
525.53K
64.26%
-360.30K
2023Q3
92
529.03K
69.17%
-298.51K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
37.74K
1.05%
+31.99K
+556.31%
Sep 30, 2025
Geode Capital Management, L.L.C.
25.89K
0.72%
+19.01K
+276.17%
Sep 30, 2025
Millennium Management LLC
17.97K
0.5%
+17.97K
--
Sep 30, 2025
Neuman (John)
8.27K
0.23%
--
--
Oct 28, 2025
Schlorff (Eric)
5.52K
0.15%
--
--
Oct 28, 2025
Trinity Financial Advisors LLC
5.00K
0.14%
+3.50K
+233.33%
Sep 30, 2025
XTX Markets LLC
4.86K
0.13%
-1.24K
-20.37%
Sep 30, 2025
Van Heel (Kenneth J.)
4.54K
0.13%
+32.00
+0.71%
Oct 28, 2025
Chung (Kevin)
3.32K
0.09%
--
--
Oct 28, 2025
Dynamic Wealth Advisors
2.93K
0.08%
+2.93K
--
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 18, 2025
Merger
10→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Date
Type
Ratio
Dec 18, 2025
Merger
10→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
Jun 06, 2024
Merger
25→1
FAQs
Who are the top five shareholders of SeaStar Medical Holding Corp?
The top five shareholders of SeaStar Medical Holding Corp are:
The Vanguard Group, Inc. holds 37.74K shares, accounting for 1.05% of the total shares.
Geode Capital Management, L.L.C. holds 25.89K shares, accounting for 0.72% of the total shares.
Millennium Management LLC holds 17.97K shares, accounting for 0.50% of the total shares.
Neuman (John) holds 8.27K shares, accounting for 0.23% of the total shares.
Schlorff (Eric) holds 5.52K shares, accounting for 0.15% of the total shares.
The Vanguard Group, Inc. holds 37.74K shares, accounting for 1.05% of the total shares.
Geode Capital Management, L.L.C. holds 25.89K shares, accounting for 0.72% of the total shares.
Millennium Management LLC holds 17.97K shares, accounting for 0.50% of the total shares.
Neuman (John) holds 8.27K shares, accounting for 0.23% of the total shares.
Schlorff (Eric) holds 5.52K shares, accounting for 0.15% of the total shares.
What are the top three shareholder types of SeaStar Medical Holding Corp?
The top three shareholder types of SeaStar Medical Holding Corp are:
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Millennium Management LLC
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Millennium Management LLC
How many institutions hold shares of SeaStar Medical Holding Corp (ICU)?
As of 2025Q4, 55 institutions hold shares of SeaStar Medical Holding Corp, with a combined market value of approximately 109.39K, accounting for 3.03% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.55%.
What is the biggest source of revenue for SeaStar Medical Holding Corp?
In --, the -- business generated the highest revenue for SeaStar Medical Holding Corp, amounting to -- and accounting for --% of total revenue.
